false --12-31 Q3 0001771995 0001771995 2024-01-01 2024-09-30 0001771995 2024-11-05 0001771995 2024-09-30 0001771995 2023-12-31 0001771995 us-gaap:RelatedPartyMember 2024-09-30 0001771995 us-gaap:RelatedPartyMember 2023-12-31 0001771995 2024-07-01 2024-09-30 0001771995 2023-07-01 2023-09-30 0001771995 2023-01-01 2023-09-30 0001771995 us-gaap:CommonStockMember 2022-12-31 0001771995 us-gaap:PreferredStockMember 2022-12-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001771995 us-gaap:RetainedEarningsMember 2022-12-31 0001771995 APHP:StockSubscriptionReceivableMember 2022-12-31 0001771995 2022-12-31 0001771995 us-gaap:CommonStockMember 2023-03-31 0001771995 us-gaap:PreferredStockMember 2023-03-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001771995 us-gaap:RetainedEarningsMember 2023-03-31 0001771995 APHP:StockSubscriptionReceivableMember 2023-03-31 0001771995 2023-03-31 0001771995 us-gaap:CommonStockMember 2023-06-30 0001771995 us-gaap:PreferredStockMember 2023-06-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001771995 us-gaap:RetainedEarningsMember 2023-06-30 0001771995 APHP:StockSubscriptionReceivableMember 2023-06-30 0001771995 2023-06-30 0001771995 us-gaap:CommonStockMember 2023-12-31 0001771995 us-gaap:PreferredStockMember 2023-12-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001771995 us-gaap:RetainedEarningsMember 2023-12-31 0001771995 APHP:StockSubscriptionReceivableMember 2023-12-31 0001771995 us-gaap:CommonStockMember 2024-03-31 0001771995 us-gaap:PreferredStockMember 2024-03-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001771995 us-gaap:RetainedEarningsMember 2024-03-31 0001771995 APHP:StockSubscriptionReceivableMember 2024-03-31 0001771995 2024-03-31 0001771995 us-gaap:CommonStockMember 2024-06-30 0001771995 us-gaap:PreferredStockMember 2024-06-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001771995 us-gaap:RetainedEarningsMember 2024-06-30 0001771995 APHP:StockSubscriptionReceivableMember 2024-06-30 0001771995 2024-06-30 0001771995 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001771995 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001771995 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001771995 APHP:StockSubscriptionReceivableMember 2023-01-01 2023-03-31 0001771995 2023-01-01 2023-03-31 0001771995 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001771995 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001771995 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001771995 APHP:StockSubscriptionReceivableMember 2023-04-01 2023-06-30 0001771995 2023-04-01 2023-06-30 0001771995 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001771995 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001771995 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001771995 APHP:StockSubscriptionReceivableMember 2023-07-01 2023-09-30 0001771995 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001771995 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001771995 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001771995 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001771995 APHP:StockSubscriptionReceivableMember 2024-01-01 2024-03-31 0001771995 2024-01-01 2024-03-31 0001771995 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001771995 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001771995 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001771995 APHP:StockSubscriptionReceivableMember 2024-04-01 2024-06-30 0001771995 2024-04-01 2024-06-30 0001771995 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001771995 us-gaap:PreferredStockMember 2024-07-01 2024-09-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001771995 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001771995 APHP:StockSubscriptionReceivableMember 2024-07-01 2024-09-30 0001771995 us-gaap:CommonStockMember 2023-09-30 0001771995 us-gaap:PreferredStockMember 2023-09-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001771995 us-gaap:RetainedEarningsMember 2023-09-30 0001771995 APHP:StockSubscriptionReceivableMember 2023-09-30 0001771995 2023-09-30 0001771995 us-gaap:CommonStockMember 2024-09-30 0001771995 us-gaap:PreferredStockMember 2024-09-30 0001771995 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001771995 us-gaap:RetainedEarningsMember 2024-09-30 0001771995 APHP:StockSubscriptionReceivableMember 2024-09-30 0001771995 us-gaap:RelatedPartyMember 2024-01-01 2024-09-30 0001771995 us-gaap:RelatedPartyMember 2023-01-01 2023-09-30 0001771995 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember APHP:CustomerMember 2024-09-30 0001771995 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember APHP:CustomerMember 2024-01-01 2024-09-30 0001771995 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember APHP:BUFFALOEDCAMAMember 2023-01-01 2023-12-31 0001771995 APHP:TwoConsultantsMember 2024-01-01 2024-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2022-11-30 0001771995 APHP:CashAssetManagementAgreementMember 2024-07-01 2024-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2023-07-01 2023-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2024-01-01 2024-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2023-01-01 2023-09-30 0001771995 APHP:BoldCrayonsMember 2024-01-01 2024-09-30 0001771995 APHP:BoldCrayonsMember us-gaap:PreferredStockMember 2024-01-01 2024-09-30 0001771995 APHP:BoldCrayonsMember us-gaap:PreferredStockMember srt:MaximumMember 2024-01-01 2024-09-30 0001771995 APHP:ConsultingServicesMember 2024-07-01 2024-09-30 0001771995 APHP:ConsultingServicesMember 2023-07-01 2023-09-30 0001771995 APHP:ConsultingServicesMember 2024-01-01 2024-09-30 0001771995 APHP:ConsultingServicesMember 2023-01-01 2023-09-30 0001771995 APHP:RiboMusicLLCMember 2023-01-01 2023-09-30 0001771995 us-gaap:ProductAndServiceOtherMember 2023-01-01 2023-09-30 0001771995 us-gaap:TradeAccountsReceivableMember 2024-09-30 0001771995 us-gaap:TradeAccountsReceivableMember 2023-12-31 0001771995 APHP:CashAssetManagementAgreementMember 2024-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2023-12-31 0001771995 us-gaap:ConvertibleDebtSecuritiesMember 2024-01-01 2024-09-30 0001771995 us-gaap:ConvertibleDebtSecuritiesMember 2023-01-01 2023-12-31 0001771995 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001771995 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001771995 2023-01-01 2023-12-31 0001771995 us-gaap:ServiceMember 2024-01-01 2024-09-30 0001771995 us-gaap:ServiceMember 2023-01-01 2023-12-31 0001771995 us-gaap:ServiceMember 2022-01-01 2022-12-31 0001771995 us-gaap:ServiceMember 2021-01-01 2021-12-31 0001771995 us-gaap:ServiceMember 2020-01-01 2020-12-31 0001771995 APHP:MasterLoanAgreementMember 2024-09-30 0001771995 APHP:MasterLoanAgreementMember 2024-01-01 2024-09-30 0001771995 srt:MinimumMember 2024-01-01 2024-09-30 0001771995 srt:MaximumMember 2024-01-01 2024-09-30 0001771995 APHP:SeniorMezzannineLoanAgreementWithBarronsCoveMovieLLCMember APHP:BarronsCoveMovieLLCMember 2024-02-29 0001771995 APHP:SeniorMezzannineLoanAgreementWithBarronsCoveMovieLLCMember 2024-02-01 2024-02-29 0001771995 APHP:SeniorMezzannineLoanAgreementWithBarronsCoveMovieLLCMember APHP:MrMacgregorMember 2024-02-01 2024-02-29 0001771995 APHP:SeniorLoanAgreementWithPNPMovieLLCMember 2024-02-29 0001771995 APHP:SeniorLoanAgreementWithPNPMovieLLCMember 2024-04-30 0001771995 APHP:SeniorLoanAgreementWithPNPMovieLLCMember 2024-01-01 2024-06-30 0001771995 APHP:SeniorLoanAgreementWithPNPMovieLLCMember 2024-06-30 2024-06-30 0001771995 APHP:WebsitePlacedInServiceMember 2024-09-30 0001771995 APHP:WebsitePlacedInServiceMember 2023-12-31 0001771995 APHP:WebsiteUnderDevelopmentMember 2024-09-30 0001771995 APHP:WebsiteUnderDevelopmentMember 2023-12-31 0001771995 APHP:SoftwarePredeploymentMember 2024-09-30 0001771995 APHP:SoftwarePredeploymentMember 2023-12-31 0001771995 APHP:MrMacgregorMember 2024-07-01 2024-09-30 0001771995 APHP:MrMacgregorMember 2024-01-01 2024-09-30 0001771995 APHP:MrMacgregorMember 2023-07-01 2023-09-30 0001771995 APHP:MrMacgregorMember 2023-01-01 2023-09-30 0001771995 APHP:MrMacgregorMember 2024-09-30 0001771995 APHP:NoahMorganPrivateFamilyTrustLoanAgreementMember 2024-02-06 0001771995 APHP:NoahMorganPrivateFamilyTrustLoanAgreementMember 2024-07-01 2024-09-30 0001771995 APHP:NoahMorganPrivateFamilyTrustLoanAgreementMember 2024-01-01 2024-09-30 0001771995 APHP:NoahMorganPrivateFamilyTrustLoanAgreementMember 2024-02-06 2024-02-06 0001771995 APHP:BoardOfDirectorsMember 2024-02-06 2024-02-06 0001771995 2021-03-31 0001771995 2021-03-01 2021-03-31 0001771995 APHP:LineOfCreditAgreementMember 2024-04-01 2024-06-30 0001771995 APHP:LineOfCreditAgreementMember 2024-06-30 0001771995 APHP:LineOfCreditAgreementMember srt:MinimumMember 2024-04-01 2024-04-30 0001771995 APHP:LineOfCreditAgreementMember srt:MaximumMember 2024-04-01 2024-04-30 0001771995 APHP:LineOfCreditAgreementMember 2024-09-30 0001771995 2024-08-15 0001771995 us-gaap:SubsequentEventMember 2024-11-05 0001771995 us-gaap:SubsequentEventMember 2024-11-05 2024-11-05 0001771995 us-gaap:SeriesAPreferredStockMember 2024-09-30 0001771995 us-gaap:SeriesAPreferredStockMember 2024-01-01 2024-09-30 0001771995 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0001771995 APHP:StockSubscriptionReceivableMember 2024-01-01 2024-09-30 0001771995 us-gaap:CommonStockMember APHP:AdvisoryAgreementsMember 2024-07-01 2024-09-30 0001771995 us-gaap:CommonStockMember APHP:AdvisoryAgreementsMember 2024-01-01 2024-09-30 0001771995 APHP:ThreeConsultantsMember 2024-01-01 2024-09-30 0001771995 us-gaap:CommonStockMember APHP:AdvisoryAgreementsMember 2023-06-01 2023-06-30 0001771995 srt:BoardOfDirectorsChairmanMember 2024-02-08 2024-02-08 0001771995 APHP:AdvisorsMember 2024-02-08 2024-02-08 0001771995 APHP:MrMacgregorMember 2024-02-08 2024-02-08 0001771995 APHP:MrBlanchardMember 2024-02-08 2024-02-08 0001771995 2024-02-08 2024-02-08 0001771995 srt:DirectorMember 2024-07-01 2024-09-30 0001771995 srt:DirectorMember 2023-07-01 2023-09-30 0001771995 srt:DirectorMember 2024-01-01 2024-09-30 0001771995 srt:DirectorMember 2023-01-01 2023-09-30 0001771995 2023-01-01 2023-01-01 0001771995 2023-01-01 0001771995 APHP:RiboMusicLLCMember 2024-07-01 2024-09-30 0001771995 APHP:RiboMusicLLCMember 2023-07-01 2023-09-30 0001771995 APHP:RiboMusicLLCMember 2024-01-01 2024-09-30 0001771995 APHP:RiboMusicLLCMember 2023-01-01 2023-09-30 0001771995 APHP:RiboMusicLLCMember 2024-09-30 0001771995 APHP:RiboMusicLLCMember 2023-12-31 0001771995 APHP:DevilsHalfAcreProductionsLLCMember 2023-07-31 0001771995 APHP:DashiellLuessenhopMember 2023-09-01 2023-09-30 0001771995 APHP:CashAssetManagementAgreementMember 2022-12-31 0001771995 APHP:BoldCrayonsMember 2022-01-01 2022-12-31 0001771995 APHP:BoldCrayonsMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001771995 APHP:MrLuessenhopMember 2022-11-10 0001771995 APHP:MrLuessenhopMember 2022-11-10 2022-11-10 0001771995 APHP:BoardOfDirectorsMember 2024-07-01 2024-09-30 0001771995 us-gaap:SubsequentEventMember APHP:SSSEntertainmentLLCMember 2024-11-11 2024-11-11 0001771995 us-gaap:SubsequentEventMember APHP:SSSEntertainmentLLCMember 2024-11-11 0001771995 us-gaap:SubsequentEventMember 2024-10-01 2024-11-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares APHP:Shareholders xbrli:pure

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

COMMISSION FILE NO. 000-56586

American Picture House Corporation

(Exact name of registrant as specified in its charter)

Wyoming

(State or other jurisdiction of incorporation)

7812

(Primary Standard Industrial Classification Code Number)

85-4154740

(IRS Employer Identification No.)

477 Madison Avenue, 6^th Floor

New York, NY 10022

1-877-416-5558

(Address and telephone number of registrant’s executive office)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
None		N/A		N/A

Securities registered pursuant to Section 12(g) of the Act: Common Stock

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant as required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by checkmark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of November 5, 2024 the Registrant had 111,399,325 shares of common stock issued and outstanding.

AMERICAN PICTURE HOUSE CORPORATION

FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2024

TABLE OF CONTENTS

		Page No.
GENERAL AND WHERE YOU CAN FIND MORE INFORMATION		1
PART I FINANCIAL INFORMATION		F-1
ITEM 1.	FINANCIAL STATEMENTS (unaudited)	F-1
CONDENSED CONSOLIDATED BALANCE SHEETS – THREE MONTHS ENDED SEPTEMBER 30, 2024 AND DECEMBER 31, 2023		F-2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - THREE MONTHS AND NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023		F-3
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY – NINE MONTHS ENDED SEPTEMBER 30, 2024		F-4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - NINE MONTHS ENDED SEPTEMBER 30, 2024 AND 2023		F-6
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS		F-7
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	2
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	7
ITEM 4.	CONTROLS AND PROCEDURES	7
PART II OTHER INFORMATION		8
ITEM 1.	LEGAL PROCEEDINGS	8
ITEM 1A.	RISK FACTORS	8
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS AND ISSUER PURCHASES OF EQUITY SECURITIES	8
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	8
ITEM 4.	MINE SAFETY DISCLOSURES	8
ITEM 5.	OTHER INFORMATION	8
ITEM 6.	EXHIBITS	8
SIGNATURES		9

General and Where You Can Find Other Information

Unless otherwise indicated, all references to the “Company,” “we,” “our,” “APH” and “APHP” refer to American Picture House Corporation a Wyoming corporation. References to “revenues” refer to net revenues. References to “U.S. dollars,” “dollars,” “U.S. $” and “$” are to the lawful currency of the United States of America.

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

AMERICAN PICTURE HOUSE CORPORATION

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF SEPTEMBER 30, 2024

INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

	Page
Condensed Consolidated Balance Sheets, September 30, 2024 (unaudited) and December 31, 2023	F-2
Condensed Consolidated Statements of Operations, for the three and nine months ended September 30, 2024 and 2023	F-3
Condensed Consolidated Statements of Changes in Deficit, for the three and nine months ended September 30, 2024 and 2023	F-4
Condensed Consolidated Statements of Cash Flows, for the nine months ended September 30, 2024 and 2023	F-6
Notes to Condensed Consolidated Financial Statements	F-7

F-1

Table of Contents

AMERICAN PICTURE HOUSE CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30, 2024			December 31, 2023
	(Unaudited)			(Audited)
ASSETS
Current Assets
Cash and cash equivalents	$	-		$	203,971
Accounts receivable		35,000			31,948
Prepaid expenses		22,031			29,185
Receivable - related party		4,086			1,349
Total Current Assets		61,117			266,453

Produced and licensed content costs		349,432			210,633
Loans receivable, film financing arrangements		396,200			-
Intangible assets, net of accumulated amortization of $13,417 and $1,000 as of September 30, 2024 and December 31, 2023, respectively.		81,447			71,864
IMM loans receivable, net of allowance of $366,387		-			-

TOTAL ASSETS		888,196			548,950

LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Cash overdraft		616			-
Accounts payable and accrued expenses		510,908			90,377
Deferred revenue, current portion		50,000			-
Interest payable - related party		8,122			-
Interest payable - EIDL loan		10,054			11,580
Note payable - related party		324,982			-
Commercial Line of Credit		107,100			-

Total Current Liabilities		1,011,782			101,957

Economic injury disaster loan, non-current		149,900			149,900

Total Liabilities		1,161,682			251,857

Stockholders’ Equity (Deficit):
Common Stock $0.0001 par value. 1,000,000,000 authorized. 111,399,325 and 109,790,991 issued and outstanding as of September 30, 2024 and December 31, 2023, respectively.		11,140			10,979
Preferred Stock $0.0001 par value. 1,000,000 authorized. 3,829 issued and outstanding as of September 30, 2024 and December 31, 2023.		-			-
Additional paid in capital		6,964,142			5,307,810
Accumulated deficit		(7,248,768	)		(5,021,696	)
Total Stockholders’ Equity (Deficit)		(273,486	)		297,093
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)	$	888,196		$	548,950

Derived from audited information

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

F-2

Table of Contents

AMERICAN PICTURE HOUSE CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	2024			2023			2024			2023
	Three Months ended September 30,						Nine Months ended September 30,
	2024			2023			2024			2023

Revenues	$	-		$	-		$	23,003		$	169,111

Cost of revenues		-			-			-			36,701
Gross profit		-			-			23,003			132,410

Operating Expenses:
General and administrative		315,570			495,257			2,197,584			1,073,980
Research and development expenses		-			8,803			703			8,803
Sales and marketing		-			-			25,325			-
Total Operating Expenses		315,570			504,060			2,223,612			1,082,783
Net Operating Loss		(315,570	)		(504,060	)		(2,200,609	)		(950,373	)

Other Income (Expenses):
Interest income		1,332			340			1,818			2,793
Interest expense		(12,276	)		(2,993	)		(28,281	)		(6,934	)
Net Other Income (Expenses)		(10,944	)		(2,653	)		(26,463	)		(4,141	)
Loss before income taxes		(326,514	)		(506,713	)		(2,227,072	)		(954,514	)
Income taxes		-			-			-			-
Net loss	$	(326,514	)	$	(506,713	)	$	(2,227,072	)	$	(954,514	)

Net loss per common share - Basic and Diluted	$	(0.00	)	$	(0.00	)	$	(0.02	)	$	(0.01	)

Weighted average shares used in per share computation - Basic and Diluted		111,399,325			107,740,991			110,845,727			103,083,257

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

F-3

Table of Contents

AMERICAN PICTURE HOUSE CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

For the nine months ended September 30, 2023

(Unaudited)

	Shares		Par Value		Shares		Amount		Capital		Deficit			Receivable			Equit (Deficit)
	Common Stock				Preferred Stock				Additional Paid In		Accumulated			Stock Subscription			Total Stockholders’
	Shares		Par Value		Shares		Amount		Capital		Deficit			Receivable			Equity (Deficit)

Balance, December 31, 2022		100,735,159	$	10,979		3,829	$	-	$	3,576,643	$	(3,655,378	)	$	-		$	(67,756	)

Conversion of accrued liabilities totaling $105,000 into options to purchase 1,160,221 shares of Common Stock		-		-		-		-		105,000		-			-			105,000

Net Loss		-		-		-		-		-		(52,340	)		-			(52,340	)

Balance, March 31, 2023		100,735,159	$	10,979		3,829	$	-	$	3,681,643	$	(3,707,718	)	$	-		$	(15,096	)

Common stock issued for services at $0.15/share		166,667		17		-		-		24,983		-			-			25,000

Issuance of Common Stock at $0.15/share		3,333,328		334		-		-		499,666		-			(40,166	)		459,834

Net Loss		-		-		-		-		-		(395,461	)		-			(395,461	)

Balance, June 30, 2023		104,235,154	$	11,330		3,829	$	-	$	4,206,292	$	(4,103,179	)	$	(40,166	)	$	74,277

Common stock issued for services at $0.20/share		666,667		67		-		-		133,266		-			-			133,333

Issuance of Common Stock		3,814,170		381		-		-		762,454		-			40,166			803,001

Net Loss		-		-		-		-		-		(506,713	)		-			(506,713	)

Balance, September 30, 2023		108,715,991	$	11,778		3,829	$	-	$	5,102,012	$	(4,609,892	)	$	-		$	503,898

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

F-4

Table of Contents

AMERICAN PICTURE HOUSE CORPORATION

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)

For the nine months ended September 30, 2024

(Unaudited)

	Common Stock				Preferred Stock				Additional Paid In		Accumulated			Stock Subscription		Total Stockholders’
	Shares		Par Value		Shares		Amount		Capital		Deficit			Receivable		Equity (Deficit)

Balance, December 31, 2023		109,790,991	$	10,979		3,829	$	-	$	5,307,810	$	(5,021,696	)	$	-	$	297,093

Issuance of Common Stock at $0.20/share		75,000		8		-		-		14,992		-			-		15,000

Stock option compensation		-		-		-		-		1,258,160		-			-		1,258,160

Net Loss		-		-		-		-		-		(1,495,987	)		-		(1,495,987	)

Balance, March 31, 2024		109,865,991	$	10,987		3,829	$	-	$	6,580,962	$	(6,517,683	)	$	-	$	74,266

Common stock issued for services at $0.25/share		917,334		91		-		-		229,242		-			-		229,333
Common stock issued for services		917,334		91		-		-		229,242		-					229,333

Issuance of Common Stock at $0.25/share		616,000		62		-		-		153,938		-			-		154,000
Issuance of Common Stock		616,000		62		-		-		153,938		-					154,000

Net Loss		-		-		-		-		-		(404,571	)		-		(404,571	)

Balance, June 30, 2024		111,399,325	$	11,140		3,829	$	-	$	6,964,142	$	(6,922,254	)	$	-	$	53,028
Balance		111,399,325	$	11,140		3,829	$	-	$	6,964,142	$	(6,922,254	)	$	-	$	53,028

Net Loss		-		-		-		-		-		(326,514	)		-		(326,514	)

Balance, September 30, 2024		111,399,325	$	11,140		3,829	$	-	$	6,964,142	$	(7,248,768	)	$	-	$	(273,486	)
Balance		111,399,325	$	11,140		3,829	$	-	$	6,964,142	$	(7,248,768	)	$	-	$	(273,486	)

F-5

Table of Contents

AMERICAN PICTURE HOUSE CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	2024			2023
	Nine Months ended September 30,
	2024			2023
Cash Flows from Operating Activities:
Net Income (Loss)	$	(2,227,072	)	$	(954,514	)
Adjustments to Reconcile Net Income (Loss) to Net Cash Flows from Operating Activities:
Reserve for uncollectible receivable	$	-		$	193,932
Expiration of produced and licensed costs		15,000			-
Stock option expense		1,258,159			-
Common stock issued for services		86,000			158,333
Amortization expense		12,417			250
Change in operating assets and liabilities:
Accounts receivable		(3,052	)		150,992
Prepaid expenses		7,154			(39,822	)
Other receivables		-			(37,888	)
Receivables - related party		(2,737	)		-
Loans receivable, film financing arrangements		(396,200	)		-
Cash overdraft		616
Accounts payable and accrued expenses		420,531			(27,349	)
Payable to related party		-			(130,000	)
Interest payable - related parties		8,122			-
Interest payable - EIDL loan		(1,526	)		4,204
Deferred revenue		50,000			(35,000	)
Net Cash Flows from Operating Activities		(772,588	)		(716,862	)

Cash Flows from Investing Activities:
Produced and licensed costs		(10,465	)		(37,153	)
Intangible assets		(22,000	)		(9,000	)
Net Cash Flows from Investing Activities		(32,465	)		(46,153	)

Cash Flows from Financing Activities:
Proceeds from debt borrowings - related parties		355,292			178,500
Repayment of debt borrowings - related parties		(30,310	)		(178,500	)
Proceeds from commercial line of credit		142,600			-
Repayment of commercial line of credit		(35,500	)		-
Proceeds from sale of Common Stock		169,000			1,262,835
Net Cash Flows from Financing Activities		601,082			1,262,835

Net (Decrease) Increase in Cash and Cash Equivalents		(203,971	)		499,820
Cash and Cash Equivalents, Beginning of Period		203,971			31,573
Cash and Cash Equivalents, End of Period	$	-		$	531,393
Non-cash Financing and Investing Activities:
Conversion of accrued expenses into options to purchase Common Stock	$	-		$	105,000

Common Stock issued for services	$	86,000		$	158,333

The accompanying notes are an integral part of these unaudited interim consolidated financial statements.

F-6

Table of Contents

AMERICAN PICTURE HOUSE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – Organization And Description Of Business

American Picture House Corporation. (“the Company,” “we,” “APHP” and “us”) was incorporated in the State of Nevada on September 21, 2005, originally under the corporate name of Servinational, Inc. The Company subsequently changed its name to Shikisai International, Inc. in November 2005 and then to Life Design Station, Intl., Inc. in August 2007. The Company changed its state of domicile from Nevada to Wyoming on October 13, 2020. On December 4, 2020, the Company changed its name to American Picture House Corporation.

The Company’s year-end is December 31.

NOTE 2 – Summary Of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).

Our interim financial statements are unaudited, and in our opinion, include all adjustments of a normal recurring nature necessary for the fair presentation of the periods presented. The results for the interim periods are not necessarily indicative of the results to be expected for any subsequent period or for the year ending December 31, 2024. These unaudited consolidated financial statements and related notes should be read in conjunction with our financial statements for the year ended December 31, 2023.

Principles of Consolidation

The condensed consolidated financial statements of the Company include the accounts of American Picture House Corporation and its wholly owned subsidiaries, Devil’s Half-Acre, LLC and Ask Christine Productions, LLC.

Use of Estimates

The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant estimates relate to income taxes and contingencies. The Company bases its estimates on historical experience, known or expected trends, and various other assumptions that are believed to be reasonable given the quality of information available as of the date of these financial statements. The results of these assumptions provide the basis for making estimates about the carrying amount of assets and liabilities that are not readily apparent from other sources. Actual results could differ from these estimates.

Cash and cash equivalents

Cash equivalents are short-term highly liquid investments which include short term bank deposits (up to three months from date of deposit), that are not restricted as to withdrawals or use that are readily convertible to cash with maturities of three months or less as of the date acquired. The Company’s policy is to maintain its cash balances with financial institutions with high credit ratings and in accounts insured by the Federal Deposit Insurance Corporation (the “FDIC”) and/or by the Securities Investor Protection Corporation (the “SIPC”). The Company may periodically have cash balances in financial institutions in excess of the FDIC and SIPC insurance limits of $250,000 and $500,000, respectively. The Company has not experienced any losses to date resulting from this policy.

F-7

Table of Contents

Accounts receivable

Accounts receivable primarily consist of trade receivables due from customers for consulting services and from fees derived from licensing of IP to content providers worldwide. As of September 30, 2024, $35,000 (100%) of accounts receivable were related to the grant of a producer credit in a proposed future film. As of December 31, 2023, 100% of accounts receivable were due from the BUFFALOED CAMA (see Assigned Rights to feature film, BUFFALOED below).

Schedule of Accounts Receivable

	September 30, 2024		December 31, 2023
Accounts receivable, trade	$	35,000	$	-
Accounts receivable, CAMA		-		31,948
Accounts receivable	$	35,000	$	31,948

Allowance for doubtful accounts

The allowance for doubtful accounts is determined with respect to amounts the Company has determined to be doubtful of collection. In determining the allowance for doubtful accounts, the Company considers, among other things, its past experience with customers, the length of time that the balance is past due, the customer’s current ability to pay and available information about the credit risk on such customers. In 2023, the Company wrote off $193,932 of receivables as bad debt based on a review of the customer’s ability to pay, the customer’s Managing Director resigning, and the customer ceasing operations. There was no bad debt expense during the quarter ended September 30, 2024. During the quarter ended June 30, 2023, the Company wrote off $193,932 of receivables as bad debt based on a review of the customer’s ability to pay. In June 2023 their Managing Director resigned and the customer ceased operations. Consequently, in the second quarter of 2023 management established an allowance for this receivable and subsequently determined that the monies due were uncollectable and therefore was written off. Management determined that no allowance for doubtful accounts is necessary at September 30, 2024 or December 31, 2023.

Prepaid expenses

At September 30, 2024, prepaid expenses consisted of prepaid insurance, prepaid licenses, and prepaid services. Prepaid expenses are amounts paid to secure the use of assets or the receipt of services at a future date or continuously over one or more future periods. When the prepaid expenses are eventually consumed, they are charged to expense. The Company had $22,031 and $29,185 in prepaid expenses as of September 30, 2024 and December 31, 2023, respectively.

Produced and Licensed Content Costs

Capitalized production costs, whether produced or acquired/ licensed rights, include development costs, direct costs and production overhead. These amounts and licensed content are included in “Produced and Licensed Content Costs” on the balance sheet as follows:

	September 30, 2024		December 31, 2023
Films in development and pre-production stage	$	349,432	$	210,633
	$	349,432	$	210,633

During the nine months ended September 30, 2024, the Company capitalized $143,333 of stock-based compensation to two consultants for services to be rendered on one of the films in pre-production.

Impairment Assessment for Investment in Films and Licensed Program Rights

A film group or individual film is evaluated for impairment when an event or change in circumstances indicates that the fair value of an individual film or film group is less than its unamortized cost.

During the quarter ended March 31, 2024, the Company allowed options to two screenplays to expire and wrote-off $15,000 of previously capitalized option costs.

F-8

Table of Contents

Assigned rights to the feature film, BUFFALOED.

In November 2022, the Company obtained certain limited rights to the feature film BUFFALOED from Bold Crayon, Inc. (“BC”), including a secured position of a one million three hundred eighty-thousand-dollar ($1,380,000.00 USD) receivable against the film’s revenues as per the film’s Cash Asset Management Agreement (“CAMA”) and a 35% share of the profits generated thereafter (“the BC Assets”). During the quarters ended September 30, 2024 and 2023, the Company reported revenues of $0 and $0, respectively, from the CAMA. During the nine months ended September 30, 2024 and 2023, the Company reported revenues of $23,003 and $0, respectively, from the CAMA. Inception to date, the Company has received $304,875 under the CAMA. Due to uncertainties of any future revenue, if any, no value has been assigned to any potential future revenues.

As partial consideration for the BC Assets being acquired by APH hereunder, APHP agreed to pay BC the first one hundred thirty thousand dollars ($130,000.00 USD) that APHP collected from the BUFFALOED and to deliver one Preferred Share to BC for each ten thousand dollars ($10,000.00 USD), in value paid to APHP from the BUFFALOED receivable above the one hundred thirty thousand dollars ($130,000.00 USD), not to exceed one hundred twenty-five (125) Preferred Shares. As of September 30, 2024, Bold Crayon was due to receive 17 Preferred Shares of APHP.

Intangible assets

The Company’s intangible assets include in-service and under-development websites and licensed internal use software. During the year ended December 31, 2023 the Company developed an external website that was placed in service during the third quarter of 2023. Additionally, during the fourth quarter of 2023 the Company began developing additional aspects of its website that went live in April 2024. During the fourth quarter of 2023, the Company licensed rights to new internal use software, but subsequently placed that project on hold and has not established a timeline for placing the software in service.

The capitalized costs of the Company’s websites placed into service were subject to straight-line amortization over a three-year period. Amortization expense totaled $5,833 and $250 for the quarters ended September 30, 2024 and 2023, respectively. Amortization expense totaled $12,417 and $250 for the nine months ended September 30, 2024 and 2023, respectively.

Deferred Revenue

Deferred revenue represents the amount billed to clients that has not yet been earned, pursuant to agreements entered into in current and prior periods. As of September 30, 2024 and December 31, 2023, total net deferred revenue was $50,000 and $0, respectively. As previously noted, the $50,000 in deferred revenue at September 30, 2024, relates to the grant of a producer credit to a proposed film.

Revenues and Costs from Services and Products – Historically, Company’s revenue comes from contracts with customers for consulting services and from the licensing and distribution of film and other entertainment rights. The consulting services typically relate to development of business strategy and monetization of intellectual property rights. The Company accounts for a contract with a customer when there is an enforceable contract between the Company and the customer, the rights of the party are identified, the contract has economic substance, and collectability of the contract is considered probable. Historically, the term of these consulting agreements has been approximately three to six months in duration. The Company’s revenue is measured based on considerations specified in the contract with each customer. Accounting Standards Codification (“ASC”) 606 allows for adoption of an “as invoiced” practical expedient that allows companies to recognize revenue in the amount to which the entity has a right to invoice when they have a right to consideration from a customer in an amount that corresponds directly with the value to the customer of the entity’s performance completed to date. The Company has elected to adopt this practical expedient with regards to its consulting services revenue. Revenues for the three months ended September 30, 2024 and 2023 totaled $0. Revenues for the nine months ended September 30, 2024 and 2023 totaled $0 and $165,000, respectively. As discussed in Note 10 – Related Party Transactions, $35,000 of the revenue for the nine months ended September 30, 2023 was from Ribo Music and the remaining $135,000 was from a second customer. The Company did not have any consulting revenues during the first nine months of 2024.

F-9

Table of Contents

Revenues from Films and Licensed Rights, are calculated based on expected ultimate revenues estimated over a period not to exceed ten years following the date of initial release of the motion picture. For an episodic television series, the period over which ultimate revenues are estimated cannot exceed ten years following the date of delivery of the first episode, or, if still in production, five years from the date of delivery of the most recent episode, if later. For titles included in acquired libraries, ultimate revenue includes estimates over a period not to exceed twenty years following the date of acquisition.

Revenue derived from the BUFFALOED CAMA totaled $0 and $0 for the quarters ended September 30, 2024 and 2023, respectively. Revenue derived from the BUFFALOED CAMA totaled $23,003 and $0 for the nine months ended September 30, 2024 and 2023, respectively.

Fair Value Measurements – The Company measures and discloses fair value in accordance with the ASC Topic 820, Fair Value Measurements and Disclosures which defines fair value, establishes a framework and gives guidance regarding the methods used for measuring fair value, and expands disclosures about fair value measurements. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions there exists a three-tier fair-value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Level 1 - unadjusted quoted prices are available in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date.

Level 2 - pricing inputs are other than quoted prices in active markets that are directly observable for the asset or liability or indirectly observable through corroboration with observable market data.

Level 3 - pricing inputs are unobservable for the non-financial asset or liability and only used when there is little, if any, market activity for the non-financial asset or liability at the measurement date. The inputs into the determination of fair value require significant management judgment or estimation. Level 3 inputs are considered as the lowest priority within the fair value hierarchy. The valuation of the right to obtain control over affiliated company, right to acquire shares of other companies, contingent consideration to be paid upon achieving of performance milestone, certain convertible bridge loans (following the maturity date and thereafter) and certain freestanding stock warrants and bifurcated convertible feature of convertible bridge loans issued to the units’ owners, fall under this category.

This hierarchy requires the Company to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value.

The fair value of cash and cash equivalents is based on its demand value, which is equal to its carrying value. Additionally, the carrying value of all other short-term monetary assets and liabilities are estimated to be equal to their fair value due to the short-term nature of these instruments.

Valuation of Long-Lived Assets – The Company evaluates whether events or circumstances have occurred which indicate that the carrying amounts of long-lived assets (principally produced and licensed content costs) may be impaired or not recoverable. The significant factors that are considered that could trigger an impairment review include: changes in business strategy, market conditions, or the manner of use of an asset; underperformance relative to historical or expected future operating results; and negative industry or economic trends. In evaluating an asset for possible impairment, management estimates that asset’s future undiscounted cash flows and appraised values to measure whether the asset is recoverable. The Company measures the impairment based on the projected discounted cash flows of the asset over its remaining life.

F-10

Table of Contents

Stock-Based Compensation – The Company follows U.S. GAAP, which requires all stock-based compensation to employees, including the grant of employee stock options, to be recognized in the statement of operations based on its fair value. Awards outstanding are accounted for using the accounting principles originally applied to the award. The expense associated with share-based compensation is recognized on a straight-line basis over the service period of each award. Refer to Note 8 for additional information related to this stock-based compensation plan.

Income taxes

The Company accounts for income taxes under FASB ASC 740, “Accounting for Income Taxes”. Under FASB ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under FASB ASC 740, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. FASB ASC 740-10-05, “Accounting for Uncertainty in Income Taxes” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.

The amount recognized is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. The Company assesses the validity of its conclusions regarding uncertain tax positions quarterly to determine if facts or circumstances have arisen that might cause it to change its judgment regarding the likelihood of a tax position’s sustainability under audit.

Net Loss per Share

Basic (loss) income per share is computed by dividing net (loss) income available to Common Stockholders by the weighted average number of common shares outstanding during the period. Diluted (loss) income per share reflects the potential dilution, using the treasury stock method that could occur if securities or other contracts to issue Common Stock were exercised or converted into Common Stock or resulted in the issuance of Common Stock that then shared in the (loss) income of the Company. In computing diluted (loss) income per share, the treasury stock method assumes that outstanding instruments are exercised/converted, and the proceeds are used to purchase Common Stock at the average market price during the period. Instruments may have a dilutive effect under the treasury stock method only when the average market price of the Common Stock during the period exceeds the exercise price/conversion rate of the instruments.

The following common share equivalents are excluded from the calculation of weighted average common shares outstanding because their inclusion would have been anti-dilutive:

	September 30, 2024		December 31, 2023
Convertible Preferred Stock		382,900,000		382,900,000
Options to Purchase Common Stock		4,583,471		-

		387,483,471		382,900,000

Segment Information

Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker (“CODM”), or decision-making group, in deciding how to allocate resources and in assessing performance. For the period of these financial statements, the CEO of the Company was the CODM. The Company views its operations and manages its business as one operating and reporting segment.

F-11

Table of Contents

New accounting standards

The Company’s management has evaluated all the recently issued, but not yet effective, accounting standards and guidance that have been issued or proposed by the FASB or other standards-setting bodies through the filing date of these financial statements and does not believe the future adoption of any such pronouncements will have a material effect on the Company’s financial position and results of operations.

Note 3 – Liquidity and Going Concern

The Company’s financial statements are prepared using account principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. As of September 30, 2024, the Company had a working capital deficit of ($950,665) and an accumulated deficit of $7,248,768. Further, as of September 30, 2024, the Company had $0 cash and had overdrawn its bank accounts by $616. These factors, among others, raise significant doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from an inability of the Company to continue as a going concern.

The Company has a limited operating history, which makes it difficult to evaluate current business and future prospects. During the first nine months of 2024, the Company reported $23,003 of revenues. During 2023, the Company reported $169,111 of service revenues, down from $461,174 in 2022 and no revenues in 2021 and 2020. Management expects the Company to incur further losses in the foreseeable future due to costs associated with content acquisition and production, the cost of on-going litigation, and costs associated with being a public company. There can be no assurance that our operations will ever generate sufficient revenues to fund continuing operations, or that we will ever generate positive cash flow from our operations, or that we will attain or thereafter sustain profitability in any future period. To mitigate this situation, the Company has loan agreements with the Company’s CEO and the Noah Morgan Private Family Trust, a trust controlled by the Company’s CEO, to fund its month-to-month cash flow needs. During the first nine months of 2024, the Company borrowed $350,292 from and repaid $30,310 to Mr. McGregor and the Noah Morgan Private Family Trust pursuant to a master loan agreement. The master note agreements accrue interest at a rate of 4.4% due and payable in a lump sum upon maturity of the obligation. These notes are not convertible. Additionally, during the nine ended September 30, 2024, the Company borrowed $142,600 under a commercial line of credit at interest rates ranging from 16.09% to 34.3%. Mr. MacGregor has personally guaranteed this line of credit.

NOTE 4. Film Production Loans

Senior Mezzanine Loan Agreement with Barron’s Cove Movie, LLC

In February 2024, the Company loaned $200,000 to Barron’s Cove Movie, LLC pursuant to a Senior Mezzanine Loan Agreement. $20,000 of the loan proceeds will be used to pay producer fees, including $10,000 to Mr. MacGregor. The $200,00 loan, plus a premium of twenty percent (20%), is due and payable on that date which is the earlier of either (a) twelve (12) months from the date of the loan, or (b) from allocable proceeds received by Barron’s Cove Movie, LLC related to the movie, whichever occurs first.

Senior Loan Agreement with PNP Movie, LLC

In February 2024, the Company agreed to loan PNP Movie, LLC $97,475 to be used solely in connection with a named feature length motion picture. In April 2024, the loan agreement was amended whereby the Company agreed to lend an additional $42,525 and to use best efforts to increase the aggregate financing to $597,475. As of June 30, 2024, a total of $196,200 had been advanced to PNP Movie, LLC. These loans, plus a premium of twenty percent (20%), is due and payable on that date which is the earlier of either (a) twelve (12) months from the date of the loan, or (b) from allocable proceeds received by PNP Movie, LLC related to the movie, whichever occurs first.

Additionally, the agreement states that Mr. MacGregor shall be entitled to a producer fee based on work to be performed and that Mr. MacGregor will receive a “Producer” credit and his son a “Co-Producer” credit on the film.

F-12

Table of Contents

NOTE 5. Intangible Assets

The identifiable intangible assets consist of the following assets:

Schedule of Intangible Assets

	September 30, 2024			December 31, 2023
Website placed in service	$	70,000		$	9,000
Website - under development		-			42,000
Software – predeployment		24,864			21,864
Intangible assets, gross		94,864			72,864

Accumulated amortization		(13,417	)		(1,000	)
Intangible assets, net	$	81,447		$	71,864

There were no impairment charges associated with the Company’s identifiable intangible assets during the three or nine month periods ended September 30, 2024 and 2023.

Amortization expense totaled $5,833 and $12,417 for the three and nine months ended September 30, 2024, respectively. Amortization expense totaled $250 and $250 for the three and nine months ended September 30, 2023, respectively.

Note 6 – Notes Payable

Note Payable – Mr. MacGregor

During the quarter and nine months ended September 30, 2024, the Company borrowed $31,884 and $70,292, respectively, from Mr. MacGregor pursuant to a master loan agreement dated March 1, 2023. During the quarter and nine months ended September 30, 2024, the Company repaid $5,010 and $30,310, respectively, under this note.

During the quarter and nine months ended September 30, 2023, the Company borrowed $238 and $178,738, respectively, from Mr. MacGregor pursuant to the master loan agreement. During the quarter and nine months ended September 30, 2023, the Company repaid $102,757 and $178,738, respectively, under this note.

The master note agreement accrues interest at a rate of 4.4% due and payable in a lump sum upon maturity of the obligation. This note is not convertible.

Noah Morgan Private Family Trust Loan Agreement (“NMPFT”)

On February 6, 2024, the Company entered into a master loan agreement with the NMPFT. The master note agreement accrues interest at a rate of 4.68%. During the quarter and nine months ended September 30, 2024, the Company borrowed $0 and $280,000 pursuant to this loan agreement with this amount due and payable in a lump sum on February 6, 2025. This note is not convertible. $200,000 of these loan proceeds were used to fund the senior mezzanine loan to Barron’s Cove Movie, LLC as more fully described in Note 4 above.

Note Payable – Board Member

During the quarter ended September 30, 2024, the Company borrowed $5,000 from a member of the Board of Directors. This note is not convertible.

Economic Injury Disaster Loan

In March 2021, the Company executed an Economic Injury Disaster Loan (“EIDL”) secured loan with the U.S. Small Business Administration under the EIDL program in the amount of $149,900. The loan is secured by all tangible and intangible assets of the Company and payable over 30 years at an interest rate of 3.75% per annum. Interest only installment payments commenced in September 2023.

Commercial Line of Credit

During April 2024, the Company entered into a line of credit agreement with American Express. During the three months ended June 30, 2024, the Company borrowed a total of $142,500 under the line and repaid principal of $29,052 resulting in a June 30, 2024 balance due on the line of $113,448. The borrowings on the line of credit bear interest at rates ranging from 16.09% to 34.3%. At present, the Company cannot draw upon the line of credit until the Company pays it down to $0. MacGregor has personally guaranteed these loans.

F-13

Table of Contents

Note 7 – Equity

Common Stock

The Company has 1,000,000,000 common shares authorized. As of Novemberr 5, 2024, the Company has 111,399,325 shares issued and outstanding. As of November 5, 2024, the total number of shareholders of record was 331.

The Common Stock has a one share one voting right with no other rights. There are no provisions in the Company’s Articles of Incorporation, Articles of Amendment, or By-laws that would delay or prevent a change of control. The Board may from time to time declare, and the Company may pay, dividends on its shares in cash, property, or its own shares, except when the Corporation is insolvent, when the payment thereof would render the Company insolvent, subject to any preferential dividend rights of outstanding shares of preferred shares or when the declaration or payment thereof would be contrary to any other state law restrictions.

Preferred Stock

The Preferred Stock consists of 1,000,000 preferred shares authorized, of which 100,000 preferred shares have been designated as Series A Convertible Preferred Stock (“Series A preferred shares” herein). At present, 3,829 Series A preferred shares are issued and outstanding. The Series A preferred shares have the following rights: (i.) a first position lien against all of the Company’s assets including but not limited to the Company’s IP (“Intellectual Property”), (ii.) is convertible at a ratio of 1 to 100,000 so that each one share of Series A preferred stock may be exchanged for 100,000 Common Stock shares, (iii.) and that each share of Series A preferred stock shall carry superior voting rights to the Company’s Common Stock and that each share of Series A preferred stock shall be counted as 1,000,000 votes in any Company vote and (iv.) and any other benefits as deemed necessary and appropriate at the time of such issuance. The Preferred shares do not have any specific redemption rights or sinking fund provisions.

The “Liquidation Preference” with respect to a share of Series A preferred stock means an amount equal to the ratio of (i.) the total amount of the Company’s assets and funds available for distribution to the Series A preferred shares to (ii.) the number of shares of Series A preferred stock outstanding. The Series A preferred stock has a liquidation preference equal to $12.02 per preferred share.

Dividend Provisions

Subject to preferential dividend rights, if any, of the holders of Preferred Stock, dividends on the Common Stock may be declared by the Board of Directors and paid out of any funds legally available therefor at such times and in such amounts as the Board of Directors shall determine.

Common Stock Activity

During the three and nine months ended September 30, 2024, the Company sold 0 and 616,000 shares of Common Stock at $0.25 per share resulting in total proceeds of $0 and $169,000, respectively. Also, during the three and nine months ended September 30, 2024, the Company issued 0 and 917,334 shares of Common Stock pursuant to advisory agreements, respectively. As stated above in Note 2, the Company capitalized $143,333 of this stock-based compensation to two consultants for consulting services to be rendered on one of the films in pre-production. The Company also recorded stock-based compensation expense totaling $86,000 to a third consultant that is included in General and Administrative Expenses.

During the quarter ended September 30, 2023, the Company sold 3,333,328 shares of Common Stock at $0.15 per share to new investors resulting in total proceeds of $500,000. Also, during June 2023, the Company issued 166,667 shares of Common Stock pursuant to an advisory agreement.

F-14

Table of Contents

Note 8– Equity Based Compensation

The American Picture House Corporation 2023 Directors, Employees and Advisors Stock Incentive and Compensation Plan (the “Plan”) was established in January 2023 to create an additional incentive to promote the financial success and progress of the Company. The Plan shall be administered by the Board of Directors and may grant options to purchase shares of the authorized but unissued Common Stock of the Company. The options may be either incentive stock options or nonqualified stock options.

The options granted under the Plan expire on the date determined by the Board of Directors and may not extend more than 10 years.

Under the Plan, unless the board specifies otherwise, stock options must be granted at an exercise price not less than the fair value of the Company’s Common Stock on the grant date. The aggregate fair value of incentive stock options held by any optionee shall not exceed $100,000.

The Board of Directors shall determine the terms and conditions of the options. The vesting requirements of all awards under the Plan may be time or event based and vary by individual grant. The incentive stock options and nonqualified stock options generally become exercisable over a two-year period. Vested and unexercised options may be available to be exercised no later than three months after termination of employment (or such longer period as determined by the Board of Directors).

Stock Option Grants

On February 8, 2024, the Company’s Board of Directors authorized the issuance of 250,000 options to each of its nine board members, 1,673,250 options to advisors, 662,983 options to Mr. Macgregor, and 497,238 options to Mr. Blanchard for an aggregate of 5,083,471 options with the rights to purchase common shares of the Company at an exercise price of $0.0125 per share. As all of the options vested 100% upon grant, the Company recorded $1,258,160 of stock option compensation expense in the quarter ended March 31, 2024. Share-based compensation expense is reported within General and Administrative expenses. During the nine months ended September 30, 2024, options to purchase 500,000 shares of Common Stock were forfeited.

Note 9 – Contingencies and Uncertainties

Risks and Uncertainties – The Company’s operations are subject to significant risks and uncertainties including financial, operational, and regulatory risks, including the potential risk of business failure. The Company does not have employment contracts with its key employees, including the controlling shareholders who are officers of the Company.

Note 10 – Related Party Transactions

The Company has agreed to indemnify Mr. MacGregor for all legal and professional costs originating from the lawsuit Randall S. Sprung v. Bannor Michael MacGregor, Jeffery Katz, and Life Design Station International, Inc. – Supreme Court of New York, County of Kings, Index No.: 504677/2019.

During the three months ended September 30, 2024 and 2023, the Company incurred approximately $80,000 and $45,000, respectively, of professional fees to a legal firm affiliated with a member of the Board of Directors. During the nine months ended September 30, 2024 and 2023, the Company incurred approximately $135,000 and $140,000, respectively, of professional fees to a legal firm affiliated with a member of the Board of Directors. As of September 30, 2024 and December 31, 2023, $50,000 and $0, respectively, were unpaid.

The Company has consulting services relationships with members of the Board whereby they were compensated a total of $15,000 and $39,000 during the three months ended September 30, 2024 and 2023, respectively. Consulting services provided by Board members totaled $45,000 and $86,000 during the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024 and December 31, 2023, $20,000 and $20,000, respectively, were accrued and unpaid. The consulting services are provided as requested by management and may be terminated at any time with no penalty. On January 1, 2023, the $105,000 of 2022 accrued consulting fees were exchanged for options to purchase 1,160,221 shares of Common Stock at $0.125 per share.

During 2022, the Company entered into consulting agreements with Ribo Music LLC aka Ribo Media (“Ribo Media”) whereby the Company assisted Ribo Media in developing an online media platform to deliver music and eventually movies directly to consumers via their smart devices. Revenues from the Ribo Media consulting services totaled $0 and $0, for the three months ended September 30, 2024 and 2023, respectively. Revenues from the Ribo Media consulting services totaled $0 and $35,000, for the nine months ended September 30, 2024 and 2023, respectively. As of September 30, 2024 and December 31, 2023, accounts receivable from Ribo Media totaled $4,086 and $0, respectively. Michael Blanchard, a director and shareholder of the Company and Timothy Battles, a director and shareholder of the Company, are both Managing Members and controlling shareholders in Ribo Media.

F-15

Table of Contents

In August 2022, the Company funded Devil’s Half-Acre Productions, LLC owned by John Luessenhop to produce the feature film Devil’s Half-Acre written and directed by Dashiell Luessenhop, a son of A. John Luessenhop, a former Board member. In July 2023 APH obtained 100% ownership of Devil’s Half-Acre Productions, LLC and executed a new option agreement with the writer. In September 2023, APH paid a Five Thousand-Dollar (5,000) option fee to the writer. This option entitles APH to produce the film by July 2024, with the ability to extend the option for an additional two (2) years. As of September 30, 2024, the Company has capitalized $151,969 of production costs associated with this film.

During 2022, the Company entered into definitive agreements to secure Bold Crayon Corporation (“Bold Crayon” or “BC”) as a development partner and purchased certain assets from Bold Crayon, including a portion of the rights to a feature film, and copyrights on six film titles. The Parties agree that APHP will designate BC as a “Content Partner”, wherein BC will develop content and present APHP with a first opportunity to co-finance and/or coproduce content developed by BC subject to a mutually agreed upon Content Partner Agreement and BC will accept such designation. The Company anticipates any rights and obligations between APH and BC to be effective upon the greenlighting of a specific film or show by Mr. MacGregor, CEO and a director of the Company, Mr. MacGregor is also the CEO and a director of Bold Crayon and effectively controls Bold Crayon as a managing manager of the trustee of the trust that owns the majority ownership interest in Bold Crayon. Mr. Michael Blanchard was a past Director and Secretary/Treasurer of Bold Crayon and is a director of APHP. The transaction between the parties has been consummated and all IP and copyrights have been transferred. During the quarters ended September 30, 2024 and 2023, the Company reported revenues of $0 and $0, respectively, from the CAMA. During the nine months ended September 30, 2024 and 2023, the Company reported revenues of $23,003 and $0, respectively, from the CAMA. Inception to date, the Company has received $304,875 under the CAMA. As partial consideration for the BC Assets being acquired by APH hereunder, APHP agreed to pay BC the first one hundred thirty thousand dollars ($130,000.00 USD) that APHP collected from the BUFFALOED and to deliver one Preferred Share to BC for each ten thousand dollars ($10,000.00 USD), in value paid to the APHP from the BUFFALOED receivable above the one hundred thirty thousand dollars ($130,000.00 USD), not to exceed one hundred twenty-five (125) Preferred Shares. As of June 30, 2024, Bold Crayon was due to receive 17 Preferred Shares of APHP.

On November 10, 2022, the Company approved the optioning of MIDNIGHT’S DOOR written by Kirsten Elms from Mr. Luessenhop for $12,700 (provided the Company produces MIDNIGHT’S DOOR as a feature film and further subject to producer agreements with Luessenhop and MacGregor). Mr. Luessenhop was a director of the Company and owned 2.005% of the Company at the time of this transaction. The Company elected to allow this option to expire during the first quarter of 2024 resulting in the expensing of $7,500 of previously capitalized costs.

On November 10, 2022 the Company entered into an additional agreement regarding THE DEVIL’S HALF-ACRE to extend additional financing in an undetermined amount to the film in exchange among other things for increased equity in the film. At the time, DEVIL’S HALF-ACRE was controlled by Mr. Luessenhop.

Note Payable – Mr. MacGregor

The master note agreement accrues interest at a rate of 4.4% due and payable in a lump sum upon maturity of the obligation. This note is not convertible.

Noah Morgan Private Family Trust Loan Agreement (“NMPFT”)

Note Payable – Board Member

During the quarter ended September 30, 2024, the Company borrowed $5,000 from a member of the Board of Directors. This note is not convertible.

NOTE 11 – SUBSEQUENT EVENTS

In accordance with FASB ASC 855-10, Subsequent Events, the Company has analyzed its operations subsequent to September 30, 2024, to the date these consolidated financial statements were issued. Except as noted below, management has determined that it does not have any material subsequent events to disclose in these consolidated financial statements.

On November 11, 2024, the Company entered into an agreement with SSS Entertainment LLC wherein the Company exchanged one million common shares of APHP and the promise to pay $725,000 on or before January 6, 2024 for a 24% beneficial ownership interest in the feature film currently titled, TURN UP THE SUN, starring James McVoy, Aisling Franciosi, and Lucas Bravo. TURN UP THE SUN is a psychological thriller, where two couples arrive at a countryside mansion they booked unknowingly together and discover strange occurrences during their stay. As part of the agreement APHP will receive an “in Association” credit for the Company and a “producer” credit for Mr. MacGregor, the Company’s CEO. The agreement also has a default provision, wherein the event of a default, specifically non-payment of the aforementioned $725,000, the Company will forfeit right to its beneficial ownership, but not the two credits and further that SSS Entertainment will receive another 500,000 common shares in APHP.

Sales of Common Stock

During the period October 1, 2024 to present, the Company sold 0 shares of Common Stock.

F-16

Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Management’s discussion and analysis of financial condition and results of operations

Organizational History of the Company and Overview

American Picture House Corporation aka American Picture House Pictures plans to be a premiere entertainment company with a focus on feature films, limited series, and content-enhancing technologies. APHP is managed by astute financiers and supported by seasoned creatives. To date, the Company has provided general consulting services to entertainment industry-based clients. These clients were interested in our entertainment industry expertise and general business knowledge. The services provided included the strategy, development, and procurement of materials including; business plans, financial projections, and corporate marketing materials for the entertainment industry. The Company has refocused its efforts and will no longer be providing these services to independent clients. Going forward, APHP plans to partner with filmmakers, showrunners, content developers and strategic technology partners to develop, package, finance, and produce high-quality feature films and television shows with broad-market appeal. The Company’s management, Board of Directors and advisors have had relationships with major studios due to many of them having worked within the entertainment industry on many films and shows in a variety of specialties including: writing, producing, directing, casting, sales, and licensing. Although these relationships have not yet yielded results to APHP to date, the Company anticipates it will be able to access these relationships to benefit the Company in its future endeavors.

The Company intends to specialize in mid-budgeted productions where more than 100% of the budget can be collateralized by a film’s or show’s intellectual property (‘IP”), unsold licensing sales projections, pre-sold licensing contracts, incentive agreements, tax rebates, and grants. The Company’s management and advisors will use these assets to limit risk and guarantee greater profitability. The IP (e.g., the book rights, script, screenplay, etc.) of a particular film or show usually has a quantifiable value, especially if such IP was written by a recognized author or by a WGA (“Writers Guild of America”) writer and further enhanced by the addition of competent producers, proven directors and directors of photography, and talented actors. While the IP itself has value, the previously mentioned elements plus the addition of factors like choosing favorable filming locales to film in (that provide monetary and/or tax incentives) and formulating lean budgets, enable third party financiers to quantify a film’s or show’s value and this quantifiable-value can be utilized to secure additional equity investors and or be utilized to secure loans. Through the development of a strong package, APHP can limit its overall financial exposure, mitigate financial risk, and reduce the equity required from the Company to produce a film or show Loans and additional equity, are usually only secured for films that have a package that has strong elements and additional factors; therefore, a reduction in equity combined with third-party participation also is expected to increase profitability to the Company.

The Company will strive to become synonymous with creative ability, financial sophistication, and leading-edge technology. The Company has optioned IP with the intent to co-finance and co-produce feature films and limited series shows.

Filmmaking Stages and Our Strategy

To understand our business strategy, it is useful to think of filmmaking in five stages - often with different teams involved at different stages:

	●	Development: The first stage in which the ideas for the film are created, rights to books/plays are acquired and the screenplay is written. Financing for the project has to be sought and obtained;
	●	Pre-Production: Arrangements and preparations are made for the shoot, such as hiring cast and film crew, selecting locations and constructing sets;
	●	Production: The raw footage and other elements for the film are recorded during the film shoot;
	●	Post-Production: The images, sound, and visual effects of the recorded film are edited and combined into a finished product; and
	●	Distribution: The completed film is distributed, marketed, and screened in cinemas and/or released to video or steaming services.

Table of Contents

Our Strategy to Build Value

Our business strategy is to purchase and/or option “entertainment properties” (e.g., book rights, screenplays, scripts, etc.). that have had some level of financial investment in the development stage before we acquire the entertainment property where the initial owner or development team decided to stop development for financial or other reasons after making a substantial investment in development. For this investment, we may share with the original team rights to revenue from the acquired entertainment properties. This strategy will allow the Company to reduce our initial cash outlay when acquiring intellectual properties, allows us to allocate more funds in moving the entertainment property up the filmmaking chain, gives us assistance and goodwill from the original development team, and reduces our financial risks.

Our strategy requires us to make an informed assessment that our management team has the ability to move the script forward where the initial team failed while allowing APHP to capitalize on the initial investment.

We seek to build value in our entertainment properties by many means, including the following:

	●	Hiring other qualified Writers Guild of America (“WGA”) writers to further develop, polish, or re-write entertainment properties;
	●	Securing or attaching quality talent (e.g., producers, director, actors, etc.);
	●	Determining pre-sales values;
	●	Securing some pre-sales (mostly in international markets);
	●	Securing financial and banking relations;
	●	Hiring a talent agency, retaining attorneys;
	●	Determining shooting locations, including the best place to obtain financial incentives and/or grants;
	●	Developing a comprehensive budget and devising financing strategy;
	●	Securing a completion bond; and
	●	Developing production and marketing materials (e.g., look-book, location scouting, poster-design, etc.).

Critical Accounting Policies and Estimates

Our management’s discussion and analysis of our financial condition and results of operations are based on our financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles, or “GAAP.” The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reported period. In accordance with GAAP, we base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

Our significant accounting policies are fully described in Note 2 to our financial statements appearing elsewhere in this Quarterly Report, and we believe those accounting policies are critical to the process of making significant judgments and estimates in the preparation of our financial statements.

COVID-19 Update

To date, the COVID-19 pandemic has not had a material impact on the Company, particularly due to our current lack of operations. The pandemic may, however, have an impact on our ability to evaluate and acquire an operating entity through a reverse merger or otherwise.

Off-Balance Sheet Arrangements

None.

Table of Contents

Results of Operations

Three Months Ended September 30, 2024 Compared to Three Months Ended September 30, 2023

The following table summarizes our results of operations for the three months ended September 30, 2024 and 2023:

	Three Months Ended September 30,
	2024			2023			Change $

Revenues	$	-		$	-		$	-

Cost of revenues		-			-			-
		-			-			-
Operating Expenses:
General and administrative		315,570			495,257			(179,687	)
Research and development		-			8,803			(8,803	)

Total Operating Expenses		315,570			504,060			(188,490	)
Net operating income (loss)		(315,570	)		(504,060	)		188,490

Other Income (Expenses):
Interest income		1,332			340			992
Interest expense		(12,276	)		(2,993	)		(9,283	)
Net Other Income (Expenses)		(10,944	)		(2,653	)		(8,291	)
Income (loss) before income taxes		(326,514	)		(506,713	)		180,199
Income taxes		-			-			-
Net income (loss)	$	(326,514	)	$	(506,713	)	$	180,199

Revenues and Cost of Revenues

The Company did not have any revenues during the quarters ended September 30, 2024 and 2023.

General and Administrative Expenses

General and administrative expenses for the three months ended September 30, 2024 were approximately $316,000 compared to approximately $495,000 for the three months ended September 30, 2023, a decrease of approximately $180,000. The 2023 period included approximately $92,000 of legal and professional fees associated with filing the Company’s Form 10 and $50,000 related to investment due diligence. Additionally, the travel expenses were approximately $21,000 higher during the 2023 period.

Research and Development Expenses

Research and development expenses for the three months ended September 30, 2024 were $0 compared to $8,803 for the nine months ended September 30, 2023.

Table of Contents

Other Income (Expense)

Interest Income. Interest income for the three months ended September 30, 2024 and 2023 was minimal and consisted of interest earned on invested cash balances.

Interest Expense. Interest expense for the three months ended September 30, 2024 and 2023 was $12,276 and $2,993, respectively, and was primarily related to our Economic Injury Disaster Loan (“EIDL”), commercial line of credit and related party working capital loans.

Liquidity and Capital Resources

We had an accumulated deficit of approximately $7.2 million, incurred a net loss of approximately $327,000, and had cash outflows from operations of approximately $773,000 as of and for the three months ended September 30, 2024. Further, we expect to continue to incur significant costs in the pursuit of our business plans. We cannot assure you that our plans to raise capital or to complete our film development and production activities will be successful. These factors, among others, raise substantial doubt about our ability to continue as a going concern.

Since our inception, we have incurred significant operating losses. We expect to incur significant expenses and operating losses for the foreseeable future as we develop and produce feature films. To date, we have funded our operations with proceeds from sales of Common Stock and borrowings from related parties under promissory notes. As of September 30, 2024, our cash and cash equivalents were negligible and we were not able to meet our current obligations as they became due and payable.

Operating Activities

During the three months ended September 30, 2024, operating activities consumed approximately $31,000 of cash, representing substantially all of the Company’s cash on hand. Accounts payable and accrued expenses increased by approximately $301,000 during the quarter due to a lack of liquidity to meet current obligations as they became due and payable.

During the three months ended September 30, 2023, operating activities used approximately $398,000 of cash, primarily resulting from our net loss of approximately $507,000, partially offset by non-cash charges and changes in our operating assets and liabilities of $108,000.

Investing Activities

During the three months ended September 30, 2024 and 2023, investing activities included approximately $2,000 and $27,000 of produced and licensed film production costs.

Financing Activities

During the three months ended September 30, 2024, net cash provided by financing activities was $26,000 which included approximately $37,000 of related party borrowings net of approximately $11,000 of debt repayments.

During the three months ended September 30, 2023, net cash provided by financing activities was approximately $700,000 including approximately $803,000 of proceeds from the sale of Common Stock partially offset by net repayments of $103,000 on related party borrowings.

Table of Contents

Nine months ended September 30, 2024 Compared to nine months ended September 30, 2023

The following table summarizes our results of operations for the nine months ended September 30, 2024 and 2023:

	Nine Months ended September 30,
	2024			2023			Change $

Revenues	$	23,003		$	169,111		$	(146,108	)

Cost of revenues		-			36,701			(36,701	)
		23,003			132,410			(109,407	)

Operating Expenses:
General and administrative		2,197,584			1,073,980			1,123,604
Research and development		703			8,803			(8,100	)
Sales and marketing		25,325			-			25,325
Total Operating Expenses		2,223,612			1,082,783			1,140,829
Net Operating Loss		(2,200,609	)		(950,373	)		(1,250,236	)

Other Income (Expenses):
Interest income		1,818			2,793			(975	)
Interest expense		(28,281	)		(6,934	)		(21,347	)
Net Other Income (Expenses)		(26,463	)		(4,141	)		(22,322	)
Loss before income taxes		(2,227,072	)		(954,514	)		(1,272,558	)
Income taxes		-			-			-
Net loss	$	(2,227,072	)	$	(954,514	)	$	(1,272,558	)

Revenues and Cost of Revenues

During the nine months ended September 30, 2023 and 2022, the Company had revenues of approximately $23,000 and $169,000, respectively. The 2024 revenues were derived from the Company’s interest in the Buffaloed CAMA. The Company’s 2023 revenue came from contracts with customers for consulting services and from the licensing and distribution of film and other entertainment rights.

General and administrative expenses for the nine months ended September 30, 2024 were approximately $2,198,000 compared to approximately $1,074,000 for the nine months ended September 30, 2023, an increase of approximately $1.1M. The increase was primarily attributable to the Company recording approximately $1,258,000 of stock option expense in the 2024 period along with a $43,000 net increase in consulting fees. The 2023 period included approximately $194,000 of bad debt expense. As a public company, we expect general and administrative costs to continue to increase in future periods.

Research and Development Expenses

Research and development expenses for the nine months ended September 30, 2024 were approximately $700 compared to $8,800 for the nine months ended September 30, 2023.

Sales and Marketing Expenses

Sales and marketing expenses for the nine months ended September 30, 2024 were approximately $25,000 compared to $0 for the three months ended September 30, 2023. Sales and marketing expenses relate to our engagement of a part-time marketing consultant during the period and related expenses.

Other Income (Expense)

Interest Income. Interest income for the nine months ended September 30, 2024 and 2023 was $1,818 and $2,793, respectively, and consisted of interest earned on invested cash balances.

Interest Expense. Interest expense for the nine months ended September 30, 2024 and 2023 was $28,281 and $6,934, respectively, and was primarily related to our Economic Injury Disaster Loan (“EIDL”) and working capital loan.

Liquidity and Capital Resources

During the first nine months of 2024, the Company sold 691,000 shares of Common Stock for $0.25 per share resulting in total proceeds of approximately $469,000. During the nine months ended September 30, 2023, the Company sold 7,147,498 shares of Common Stock at prices between $0.15 and $0.20 per share resulting in total proceeds of approximately $716,000. We had an accumulated deficit of approximately $7.2 million, incurred a net loss of approximately $2.2 million, and had cash outflows from operations of approximately $773,000 as of and for the nine months ended September 30, 2024. Further, we expect to continue to incur significant costs in the pursuit of our business plans. We cannot assure you that our plans to raise capital or to complete our film development and production activities will be successful. These factors, among others, raise substantial doubt about our ability to continue as a going concern.

Since our inception, we have incurred significant operating losses. We expect to incur significant expenses and operating losses for the foreseeable future as we develop and produce feature films. To date, we have funded our operations with proceeds from sales of Common Stock and borrowings from related parties under promissory notes. As of September 30, 2024, we had cash and cash equivalents of approximately $0.

Operating Activities

During the nine months ended September 30, 2024, operating activities consumed substantially all of the Company’s available cash resources of approximately $773,000.

During the nine months ended September 30, 2023, operating activities used approximately $717,000 of cash, primarily resulting from our net loss of approximately $954,000, partially offset by non-cash charges and changes in our operating assets and liabilities of $238,000.

Table of Contents

Investing Activities

During the nine months ended September 30, 2024 and 2023, investing activities included approximately $10,000 and $37,000 of produced and licensed film production costs. Additionally, during the 2024 and 2023 periods, the Company invested approximately $22,000 and $9,000 in website development costs, respectively.

Financing Activities

During the nine months ended September 30, 2024, net cash provided by financing activities was approximately $601,000 including $169,000 of proceeds from the sale of Common Stock and $432,000 from net related party borrowings.

During the nine months ended September 30, 2023, net cash provided by financing activities was $1.3 million of proceeds from the sale of Common Stock. Additionally, during 2023 period the Company borrowed and fully repaid $178,500 under a promissory note with the Company’s chief executive officer.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There have been no material changes to our market risk during the first nine months of 2024. For a discussion of our exposure to market risk, please see Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk” of our 2023 Form 10-K.

ITEM 4. CONTROLS AND PROCEDURES

(a)	Disclosure Controls and Procedures.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September 30, 2024, or the Evaluation Date. Based on such evaluation, those officers have concluded that, as of the Evaluation Date, our disclosure controls and procedures are ineffective in recording, processing, summarizing and reporting, on a timely basis, information required to be included in periodic filings under the Exchange Act and that such information is not accumulated and communicated to management, including our principal executive and financial officers, in a manner sufficient to allow timely decisions regarding required disclosure, due to lack of sufficient internal accounting personnel, segregation of duties, lack of sufficient internal controls (including IT general controls) that encompass the Company as a whole with respect to entity and transactions level controls in order to ensure complete documentation of complex and non-routine transactions and adequate financial reporting.

Management has identified corrective actions to remediate such material weaknesses, and subject to fundraising, which includes hiring additional employees. Management intends to implement procedures to remediate such material weaknesses during the fiscal year 2024; however, the implementation of these initiatives may not fully address any material weakness or other deficiencies that we may have in our disclosure controls and procedures.

(b)

Changes in Internal Control over Financial Reporting.

During the nine months ended September 30, 2024, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II - OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We may from time to time be involved in various claims and legal proceedings of a nature we believe are normal and incidental to our business. These matters may include product liability, intellectual property, employment, personal injury cause by our employees, and other general claims. Aside from the following, we are not presently a party to any legal proceedings that, in the opinion of our management, are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Pending Legal Proceeding(s).

Randall S. Sprung v. Bannor Michael MacGregor, Jeffery Katz, and Life Design Station International, Inc. – Supreme Court of New York, County of Kings, Index No.: 504677/2019

This action instituted by Randall Sprung against the Defendants on March 4, 2019, to recover monies he alleges are owed by Defendants (Counter-Plaintiffs) pursuant to written agreements to purchase shares and to provide consulting services between the parties. Defendants Bannor Michael MacGregor and Life Design Station International, Inc. (“LDSI”) (Counter-Plaintiffs) have filed counterclaims to recover damages they have incurred as a direct result of Sprung’s failure to properly perform his obligations and duties under the written agreement between the parties.

In February 2022, Plaintiff Sprung passed away. On May 25, 2023, the Court entered an Order substituting David Sprung, as Administrator of the Estate of Randall S. Sprung, for Randall S. Sprung as Defendant in the action.

The Defendants continue to pursue their counterclaims and to defend against Plaintiff’s claims vigorously.

ITEM 1A. RISK FACTORS

Not applicable.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There are no transactions that have not been previously included in a Current Report on Form 8-K.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION

Not applicable.

ITEM 6. EXHIBITS INDEX

3.1	Second Amended and Restated Articles of Incorporation
3.2	Bylaws
3.3	Devil’s Half-Acre Articles of Organization
3.4	Ask Christine Articles of Organization
10.1	Consulting Agreement with Bannor Michael MacGregor
10.1.1	Amended Consulting Agreement with Bannor Michael MacGregor
10.1.2	Sanger Consulting Agreement
10.2	Economic Injury Disaster Loan (EIDL)
10.3	American Express Business Line of Credit Loan Agreement and Personal Guarantee
10.4	2023 Directors, Employees and Advisors Stock Incentive and Compensation Plan
10.5	Asset Purchase Agreement with Bold Crayon
10.6	Devil’s Half-Acre Agreement
10.6.1	Devil’s Half-Acre Addendum
10.7	Ask Christine Screenplay Options Purchase Agreement
10.8	Master Loan Agreement between APHP and Bannor MacGregor
10.9	PNP Senior Loan Agreement
10.9.1	Addendum to PNP Agreement
10.10	Barron’s Cove Loan Agreement
10.10.1	Addendum to Barron’s Cove Agreement
10.11	Screenplay Option for Coyote Sleeps
14.1	Code of Ethics
14.2	Code of Ethics For Executive Officers
31.1	Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer
31.2	Rule 13(a)-14(a)/15(d)-14(a) Certification of principal financial officer
32.1	Section 1350 Certification of principal executive officer
32.2	Section 1350 Certification of principal financial officer and principal accounting officer
101.INS	Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH	Inline XBRL Taxonomy Extension Schema
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase
101.DEF	Inline XBRL Taxonomy Extension Definition Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase
104	Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

Table of Contents

AMERICAN PICTURE HOUSE CORPORATION

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	AMERICAN PICTURE HOUSE CORPORATION

	By:	/s/ Bannor Michael MacGregor
	Name:	Bannor Michael MacGregor
	Title:	Chief Executive Officer
	Dated:	November 13, 2024

By:

/s/ Daniel Hirsch

Treasurer

November 13, 2024

American Picture House Corp 10-Q